BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 38539517)

  • 1. Molecular Pathology of Pancreatic Cystic Lesions with a Focus on Malignant Progression.
    Hu Y; Jones D; Esnakula AK; Krishna SG; Chen W
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project.
    Semaan A; Bernard V; Wong J; Makino Y; Swartzlander DB; Rajapakshe KI; Lee JJ; Officer A; Schmidt CM; Wu HH; Scaife CL; Affolter KE; Nachmanson D; Firpo MA; Yip-Schneider M; Lowy AM; Harismendy O; Sen S; Maitra A; Jakubek YA; Guerrero PA
    Cancer Res Commun; 2023 Oct; 3(10):2062-2073. PubMed ID: 37721516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Performance of Endoscopic Ultrasound-Based Techniques in Patients With Pancreatic Cystic Lesions: A Network Meta-Analysis.
    Li SY; Wang ZJ; Pan CY; Wu C; Li ZS; Jin ZD; Wang KX
    Am J Gastroenterol; 2023 Feb; 118(2):243-255. PubMed ID: 36563321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.
    Amato E; Molin MD; Mafficini A; Yu J; Malleo G; Rusev B; Fassan M; Antonello D; Sadakari Y; Castelli P; Zamboni G; Maitra A; Salvia R; Hruban RH; Bassi C; Capelli P; Lawlor RT; Goggins M; Scarpa A
    J Pathol; 2014 Jul; 233(3):217-27. PubMed ID: 24604757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic
    Fujikura K; Hosoda W; Felsenstein M; Song Q; Reiter JG; Zheng L; Beleva Guthrie V; Rincon N; Dal Molin M; Dudley J; Cohen JD; Wang P; Fischer CG; Braxton AM; Noë M; Jongepier M; Fernández-Del Castillo C; Mino-Kenudson M; Schmidt CM; Yip-Schneider MT; Lawlor RT; Salvia R; Roberts NJ; Thompson ED; Karchin R; Lennon AM; Jiao Y; Wood LD
    Gut; 2021 May; 70(5):928-939. PubMed ID: 33028669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
    Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
    Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms.
    Huang B; Trujillo MA; Fujikura K; Qiu M; Chen F; Felsenstein M; Zhou C; Skaro M; Gauthier C; Macgregor-Das A; Hutchings D; Hong SM; Hruban RH; Eshleman JR; Thompson ED; Klein AP; Goggins M; Wood LD; Roberts NJ
    J Pathol; 2020 Nov; 252(3):252-262. PubMed ID: 32696980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes of EUS-guided ablation and surveillance only for pancreatic cystic lesions: a propensity score-matching study (with videos).
    Song YJ; Huh G; Kim EH; Lee JB; Park DH
    Gastrointest Endosc; 2023 Oct; 98(4):585-596.e3. PubMed ID: 37211286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary mucinous neoplasm--when to resect?
    Waters JA; Schmidt CM
    Adv Surg; 2008; 42():87-108. PubMed ID: 18953811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).
    Das KK; Xiao H; Geng X; Fernandez-Del-Castillo C; Morales-Oyarvide V; Daglilar E; Forcione DG; Bounds BC; Brugge WR; Pitman MB; Mino-Kenudson M; Das KM
    Gut; 2014 Oct; 63(10):1626-34. PubMed ID: 24277729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma.
    Jiang J; Chao WL; Culp S; Krishna SG
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New guidelines for use of endoscopic ultrasound for evaluation and risk stratification of pancreatic cystic lesions may be too conservative.
    Sahar N; Razzak A; Kanji ZS; Coy DL; Kozarek R; Ross AS; Gluck M; Larsen M; Irani S; Gan SI
    Surg Endosc; 2018 May; 32(5):2420-2426. PubMed ID: 29288277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy and agreement of a large panel of endosonographers for endomicroscopy-guided virtual biopsy of pancreatic cystic lesions.
    Machicado JD; Napoleon B; Lennon AM; El-Dika S; Pereira SP; Tan D; Pannala R; Girotra M; Kongkam P; Bertani H; Feng Y; Sijie H; Zhong N; Valantin V; Leblanc S; Hinton A; Krishna SG
    Pancreatology; 2022 Nov; 22(7):994-1002. PubMed ID: 36089484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Pancreatic Cyst Management: Artificial Intelligence-Powered Prediction of Advanced Neoplasms through Endoscopic Ultrasound-Guided Confocal Endomicroscopy.
    Jiang J; Chao WL; Cao T; Culp S; Napoléon B; El-Dika S; Machicado JD; Pannala R; Mok S; Luthra AK; Akshintala VS; Muniraj T; Krishna SG
    Biomimetics (Basel); 2023 Oct; 8(6):. PubMed ID: 37887627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations.
    Fischer CG; Beleva Guthrie V; Braxton AM; Zheng L; Wang P; Song Q; Griffin JF; Chianchiano PE; Hosoda W; Niknafs N; Springer S; Dal Molin M; Masica D; Scharpf RB; Thompson ED; He J; Wolfgang CL; Hruban RH; Roberts NJ; Lennon AM; Jiao Y; Karchin R; Wood LD
    Gastroenterology; 2019 Oct; 157(4):1123-1137.e22. PubMed ID: 31175866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.
    Omori Y; Ono Y; Tanino M; Karasaki H; Yamaguchi H; Furukawa T; Enomoto K; Ueda J; Sumi A; Katayama J; Muraki M; Taniue K; Takahashi K; Ambo Y; Shinohara T; Nishihara H; Sasajima J; Maguchi H; Mizukami Y; Okumura T; Tanaka S
    Gastroenterology; 2019 Feb; 156(3):647-661.e2. PubMed ID: 30342036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic Ultrasound-Guided Needle-Based Confocal Endomicroscopy as a Diagnostic Imaging Biomarker for Intraductal Papillary Mucinous Neoplasms.
    Krishna S; Abdelbaki A; Hart PA; Machicado JD
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation.
    Ren R; Krishna SG; Chen W; Frankel WL; Shen R; Zhao W; Avenarius MR; Garee J; Caruthers S; Jones D
    Mod Pathol; 2021 Feb; 34(2):438-444. PubMed ID: 32792597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.